Clinical trial Recruiting at 2 sites Observational Ages 18 and up Men only

Male Hypogonadism: How Stigma and Identity relate to Quality of Life

Official title: The Impact of Anticipated Illness Stigma and Illness Identity on Quality of Life in Men With Hypogonadism: A Comparative Study With Other Chronic Endocrine Diseases

Run by Hacettepe University · NCT07752511 · Data updated 2026-11-12

This study tests whether men with hypogonadism feel more anticipated stigma and have a different illness identity compared with men with other chronic endocrine conditions, and whether those psychosocial factors predict quality of life.

More Hypertension trials

Quick facts

Study typeObservational
Ages18 Years and up
SexMen only
Enrollment90 (estimated)
SponsorHacettepe University
Academic / other
Locations2 sites (Bingoel and 1 other locations)
StatusRecruiting
StartedOctober 20, 2026
Main results expectedOctober 20, 2027
Study endsOctober 30, 2027
Registry record updatedNovember 6, 2026
Trial IDNCT07752511 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Men 18 years or older with biochemically confirmed hypogonadism, and age‑matched men with diabetes, hypertension, or hypothyroidism as controls, all under endocrinology care and fluent in Turkish.

Probably not a fit

Results may be less informative for individuals without clinically confirmed hypogonadism or those not fluent in Turkish.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study compares levels of anticipated illness stigma and illness identity in men with hypogonadism to age‑matched men with other chronic endocrine diseases seen in the same clinic. It also explores whether these psychosocial factors predict quality‑of‑life changes within the hypogonadism group. Participants are adult men, with cases having biochemically confirmed hypogonadism and controls having diabetes, hypertension, or hypothyroidism, all under endocrinology care. Inclusion requires Turkish literacy and informed consent; exclusion criteria include active psychiatric illness and certain inflammatory or rheumatic diseases. The study is led by Hacettepe University with collaboration from Turkish clinical sites in Bingöl and Malatya.

Why it matters

Potential benefit: Findings could illuminate psychosocial targets to improve quality of life for men with hypogonadism.

How similar studies have gone: Previous work has explored stigma and illness identity in chronic conditions, but this specific comparison in hypogonadism is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

Cases:

* Male, aged 18 years or older.
* Biochemically confirmed hypogonadism (total testosterone \< 300 ng/dL with at least one clinical symptom).
* Regular follow-up at the endocrinology outpatient clinic.
* Fluent in reading and understanding Turkish.
* Signed informed consent.

Controls:

* Male, aged 18 years or older.
* Diagnosed with diabetes, hypertension, or hypothyroidism under regular endocrinology follow-up.
* Total testosterone ≥ 300 ng/dL.
* Age-matched to a participant in the case group (±5 years).
* Fluent in reading and understanding Turkish.
* Signed informed consent.

Exclusion Criteria:

* Active psychiatric diagnosis (e.g., active psychosis, bipolar disorder).
* Chronic inflammatory or rheumatological diseases affecting body composition (e.g., chronic kidney disease, IBD, rheumatoid arthritis, SLE, ankylosing spondylitis).
* Uncontrolled co-existing endocrine conditions or severe complications (e.g., HbA1c \> 8.0%, diabetic neuropathy/nephropathy/retinopathy, non-euthyroid state).
* Cognitive impairment or dementia precluding questionnaire completion.
* Klinefelter syndrome.
* Literacy limitations preventing completion of self-report measures.
* Additional control exclusion: Diagnosis or clinical suspicion of hypogonadism.

Where it's running

  • Bingöl University Faculty of Physical Therapy and Rehabilitation
    Bingoel, Turkey (Türkiye)
    Recruiting
  • Malatya Training and Research Hospital
    Malatya, Turkey (Türkiye)
    Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.